Annual EBIT
-$45.31 M
+$106.07 M+70.07%
31 December 2021
Summary:
Aerie Pharmaceuticals annual earnings before interest & taxes is currently -$45.31 million, with the most recent change of +$106.07 million (+70.07%) on 31 December 2021. During the last 3 years, it has risen by +$106.07 million (+70.07%).AERI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$25.08 M
-$6.94 M-38.29%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly earnings before interest & taxes is currently -$25.08 million, with the most recent change of -$6.94 million (-38.29%) on 30 September 2022.AERI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$23.24 M
+$7.19 M+23.64%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM earnings before interest & taxes is currently -$23.24 million, with the most recent change of +$7.19 million (+23.64%) on 30 September 2022.AERI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +70.1% | +22.3% | +82.5% |
| 5 y5 years | +78.4% | +41.4% | +86.0% |
AERI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +480.0% | -146.8% | +549.7% |
Aerie Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$25.08 M(+38.3%) | -$23.24 M(-23.6%) |
| June 2022 | - | -$18.14 M(-46.0%) | -$30.43 M(-31.0%) |
| Mar 2022 | - | -$33.56 M(-162.7%) | -$44.09 M(-3.2%) |
| Dec 2021 | -$45.31 M(-70.1%) | $53.54 M(-265.9%) | -$45.55 M(-65.8%) |
| Sept 2021 | - | -$32.27 M(+1.5%) | -$133.09 M(-0.5%) |
| June 2021 | - | -$31.79 M(-9.3%) | -$133.74 M(-6.9%) |
| Mar 2021 | - | -$35.03 M(+3.1%) | -$143.63 M(-5.1%) |
| Dec 2020 | -$151.38 M(-19.3%) | -$33.99 M(+3.2%) | -$151.38 M(-10.6%) |
| Sept 2020 | - | -$32.93 M(-21.0%) | -$169.24 M(-5.5%) |
| June 2020 | - | -$41.67 M(-2.6%) | -$179.10 M(-2.1%) |
| Mar 2020 | - | -$42.79 M(-17.5%) | -$183.04 M(-2.4%) |
| Dec 2019 | -$187.49 M(-10.6%) | -$51.85 M(+21.1%) | -$187.49 M(+12.9%) |
| Sept 2019 | - | -$42.80 M(-6.2%) | -$166.01 M(-20.1%) |
| June 2019 | - | -$45.60 M(-3.5%) | -$207.84 M(-4.1%) |
| Mar 2019 | - | -$47.24 M(+55.6%) | -$216.79 M(+3.4%) |
| Dec 2018 | -$209.74 M(+44.0%) | -$30.37 M(-64.1%) | -$209.74 M(-12.8%) |
| Sept 2018 | - | -$84.63 M(+55.1%) | -$240.42 M(+28.2%) |
| June 2018 | - | -$54.56 M(+35.7%) | -$187.52 M(+16.7%) |
| Mar 2018 | - | -$40.19 M(-34.2%) | -$160.74 M(+10.3%) |
| Dec 2017 | -$145.69 M | -$61.04 M(+92.4%) | -$145.69 M(+28.0%) |
| Sept 2017 | - | -$31.73 M(+14.2%) | -$113.83 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$27.78 M(+10.5%) | -$105.28 M(+5.2%) |
| Mar 2017 | - | -$25.14 M(-13.8%) | -$100.05 M(+3.3%) |
| Dec 2016 | -$96.87 M(+35.0%) | -$29.18 M(+25.9%) | -$96.87 M(+10.7%) |
| Sept 2016 | - | -$23.18 M(+2.8%) | -$87.53 M(+7.2%) |
| June 2016 | - | -$22.55 M(+2.6%) | -$81.62 M(+5.9%) |
| Mar 2016 | - | -$21.97 M(+10.8%) | -$77.08 M(+7.5%) |
| Dec 2015 | -$71.73 M(+51.0%) | -$19.84 M(+14.9%) | -$71.73 M(+5.8%) |
| Sept 2015 | - | -$17.26 M(-4.2%) | -$67.77 M(+6.5%) |
| June 2015 | - | -$18.01 M(+8.4%) | -$63.65 M(+10.8%) |
| Mar 2015 | - | -$16.62 M(+4.7%) | -$57.46 M(+20.9%) |
| Dec 2014 | -$47.51 M(+73.7%) | -$15.87 M(+20.7%) | -$47.51 M(+15.9%) |
| Sept 2014 | - | -$13.15 M(+11.3%) | -$40.98 M(+10.4%) |
| June 2014 | - | -$11.81 M(+77.1%) | -$37.11 M(+21.6%) |
| Mar 2014 | - | -$6.67 M(-28.7%) | -$30.53 M(+11.6%) |
| Dec 2013 | -$27.35 M(+83.5%) | -$9.35 M(+0.9%) | -$27.35 M(+27.3%) |
| Sept 2013 | - | -$9.27 M(+77.1%) | -$21.49 M(+36.1%) |
| June 2013 | - | -$5.23 M(+49.7%) | -$15.79 M(+49.6%) |
| Mar 2013 | - | -$3.50 M(+0.3%) | -$10.56 M(+49.5%) |
| Dec 2012 | -$14.90 M(+15.9%) | -$3.48 M(-2.6%) | -$7.06 M(+97.4%) |
| Sept 2012 | - | -$3.58 M | -$3.58 M |
| Dec 2011 | -$12.86 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AERI is -$45.31 M
What is the all time high annual EBIT for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.81 M
What is Aerie Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AERI is -$25.08 M
What is the all time high quarterly EBIT for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly earnings before interest & taxes is $53.54 M
What is Aerie Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AERI is -$23.24 M
What is the all time high TTM EBIT for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM earnings before interest & taxes is -$3.58 M